These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7923554)
1. Disposition of leucovorin and its metabolites in the plasma, intestinal epithelium, and intraperitoneal L1210 cells of methotrexate-pretreated mice. Bunni MA; Sirotnak FM; Otter GM; Priest DG Cancer Chemother Pharmacol; 1994; 34(6):455-8. PubMed ID: 7923554 [TBL] [Abstract][Full Text] [Related]
2. Relationship of reduced folate changes to inhibition of DNA synthesis induced by methotrexate in L1210 cells in vivo. Priest DG; Bunni M; Sirotnak FM Cancer Res; 1989 Aug; 49(15):4204-9. PubMed ID: 2743307 [TBL] [Abstract][Full Text] [Related]
3. Disposition of leucovorin and its metabolites in dietary folic acid-deplete mice - comparison between tumor, liver, and plasma. Raghunathan K; Schmitz JC; Priest DG Cancer Chemother Pharmacol; 1997; 40(2):126-30. PubMed ID: 9182833 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously. Priest DG; Schmitz JC; Bunni MA; Stuart RK J Natl Cancer Inst; 1991 Dec; 83(24):1806-12. PubMed ID: 1744924 [TBL] [Abstract][Full Text] [Related]
5. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate. Zhao R; Babani S; Gao F; Liu L; Goldman ID Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762 [TBL] [Abstract][Full Text] [Related]
6. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro. Matherly LH; Czajkowski CA; Muench SP; Psiakis JT Cancer Res; 1990 Jun; 50(11):3262-9. PubMed ID: 2139802 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells. Boarman DM; Baram J; Allegra CJ Biochem Pharmacol; 1990 Dec; 40(12):2651-60. PubMed ID: 2260989 [TBL] [Abstract][Full Text] [Related]
8. l-5-formyltetrahydrofolate and l-5-methyltetrahydrofolate rescue in L1210 leukemia treated with high methotrexate doses. Simile MM; DeMiglio MR; Nufris A; Pascale RM; Muroni MR; Feo F Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):251-4. PubMed ID: 8210704 [TBL] [Abstract][Full Text] [Related]
9. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells. BaliĆska M Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275 [TBL] [Abstract][Full Text] [Related]
10. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates. Goldman ID; Matherly LH NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654 [TBL] [Abstract][Full Text] [Related]
11. Effects of methotrexate on folates in Krebs ascites and L1210 murine leukemia cells. Kesavan V; Sur P; Doig MT; Scanlon KJ; Priest DG Cancer Lett; 1986 Jan; 30(1):55-9. PubMed ID: 3943080 [TBL] [Abstract][Full Text] [Related]
12. The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts. Houghton JA; Schmidt C; Houghton PJ Eur J Cancer Clin Oncol; 1982 Apr; 18(4):347-54. PubMed ID: 6889511 [TBL] [Abstract][Full Text] [Related]
13. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell. Seither RL; Rape TJ; Goldman ID Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676 [TBL] [Abstract][Full Text] [Related]
14. Role of methylenetetrahydrofolate depletion in methotrexate-mediated intracellular thymidylate synthesis inhibition in cultured L1210 cells. Bunni M; Doig MT; Donato H; Kesavan V; Priest DG Cancer Res; 1988 Jun; 48(12):3398-404. PubMed ID: 3370638 [TBL] [Abstract][Full Text] [Related]
15. Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo. Sirotnak FM; Goutas LJ; Mines LS Cancer Res; 1985 Oct; 45(10):4732-4. PubMed ID: 3875399 [TBL] [Abstract][Full Text] [Related]
16. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells. Matherly LH; Barlowe CK; Goldman ID Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428 [TBL] [Abstract][Full Text] [Related]
17. The effects on 4-aminoantifolates on 5-formyltetrahydrofolate metabolism in L1210 cells. A biochemical basis of the selectivity of leucovorin rescue. Matherly LH; Barlowe CK; Phillips VM; Goldman ID J Biol Chem; 1987 Jan; 262(2):710-7. PubMed ID: 2948949 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of tetrahydrofolates in human plasma after leucovorin administration. Bunni MA; Rembiesa BM; Priest DG; Sahovic E; Stuart R Cancer Chemother Pharmacol; 1989; 23(6):353-7. PubMed ID: 2785439 [TBL] [Abstract][Full Text] [Related]
19. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252 [TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model. Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]